Therapeutics: Discoidin domain receptor tyrosine kinase 1 (DDR1); Notch pathway; K-Ras (KRAS)

Cancer

INDICATION: Lung cancer

Patient sample and mouse studies suggest combining inhibitors of DDR1 and the Notch pathway could help treat KRAS-mutant lung cancer. In 554 tumor samples from patients

Read the full 280 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE